Children's Mercy Hospital
Kansas City, Missouri, 64108, United States
NCT Number: NCT06412601
The goal of this clinical trial is to evaluate the impact of peer support via the Happy Bob phone app in youth with Type 1 Diabetes.
The main questions it aims to answer are: What is the usability and acceptability of the app? What is the app's efficacy on measures such as treatment adherence and social support? And how are these effects impacted by remote patient monitoring by clinic staff?
Participants will use the Happy Bob app for 6 months and will complete a series of surveys at the start, middle, and end of their use of the app. Some participants will participate in 2 remote patient monitoring sessions when beginning their use of the app.
This study is active but is not currently recruiting participants.
Notify Me13 year–215 month
All sexes
Interventional
Not applicable
Kansas City, Missouri, 64108, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Diagnosis of Type 1 Diabetes, Use Dexcom and Smart Phone
Exclusion criteria
Non-English Speaking
remote patient monitoring by clinic staff
use of Happy Bob phone app
Time frame: 6 months
time spent in Happy Bob,
Time frame: 0,3,6 months
quality of life scale
Time frame: 0,3,6 months
mood scale
Time frame: 0,3,6 months
intervention satisfaction
Time frame: 0,3,6 months
social quality of life
Time frame: 0,3,6 months
usability scale
Time frame: 0,3,6 months
efficacy scale
Time frame: 6 months
TIR,
Children's Mercy Hospital Kansas City
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06160934
Autoimmune Diseases, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial DetailsNCT05949281
Autoimmune Diseases, Cardiovascular Diseases
Hellerup, Capital Region, Denmark
View Trial DetailsNCT07039942
Autoimmune Diseases, Diabetes
Angers, France
View Trial DetailsNCT05268250
Autoimmune Diseases, Diabetes Mellitus
Jacksonville, Florida, United States
View Trial Details